These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32108353)

  • 1. Red cell alloimmunization: A 2020 update.
    Castleman JS; Kilby MD
    Prenat Diagn; 2020 Aug; 40(9):1099-1108. PubMed ID: 32108353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of red blood cell alloimmunization in pregnancy.
    Ghesquière L; Garabedian C; Coulon C; Verpillat P; Rakza T; Wibaut B; Delsalle A; Subtil D; Vaast P; Debarge V
    J Gynecol Obstet Hum Reprod; 2018 May; 47(5):197-204. PubMed ID: 29476829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the rate of decline in fetal hemoglobin levels between first and second transfusions in red cell alloimmune disease.
    Nishie EN; Liao AW; Brizot Mde L; Assunção RA; Zugaib M
    Prenat Diagn; 2012 Dec; 32(12):1123-6. PubMed ID: 22949399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACOG Practice Bulletin No. 192: Management of Alloimmunization During Pregnancy.
    Obstet Gynecol; 2018 Mar; 131(3):e82-e90. PubMed ID: 29470342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and prevention of red cell alloimmunization in pregnancy: a systematic review.
    Moise KJ; Argoti PS
    Obstet Gynecol; 2012 Nov; 120(5):1132-9. PubMed ID: 23090532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACOG Practice Bulletin No. 192 Summary: Management of Alloimmunization During Pregnancy.
    Obstet Gynecol; 2018 Mar; 131(3):611-612. PubMed ID: 29470338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for the fetus with alloimmune hemolytic disease.
    Bowman JM
    Transfus Med Rev; 1990 Jul; 4(3):191-207. PubMed ID: 2134630
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome.
    Smits-Wintjens VE; Rath ME; Lindenburg IT; Oepkes D; van Zwet EW; Walther FJ; Lopriore E
    Neonatology; 2012; 101(4):306-10. PubMed ID: 22354012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
    Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
    Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine transfusion in an Rh-immunized twin pregnancy: a case report of successful outcome and a review of the literature.
    Manning FA; Bowman JM; Lange IR; Chamberlain PF
    Obstet Gynecol; 1985 Mar; 65(3 Suppl):2S-6S. PubMed ID: 3919348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intrauterine transfusion in severe red blood cell alloimmunization.
    Yinon Y; Visser J; Kelly EN; Windrim R; Amsalem H; Seaward PG; Ryan G
    Ultrasound Obstet Gynecol; 2010 Nov; 36(5):601-6. PubMed ID: 20509139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modern diagnosis and therapy of fetomaternal blood group incompatibility].
    Vetter K; Favre Y
    Arch Gynecol Obstet; 1990; 247 Suppl():S25-35. PubMed ID: 2128174
    [No Abstract]   [Full Text] [Related]  

  • 13. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization.
    Inglis SR; Lysikiewicz A; Sonnenblick AL; Streltzoff JL; Bussel JB; Chervenak FA
    Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of rhesus alloimmunization in pregnancy.
    Moise KJ
    Obstet Gynecol; 2008 Jul; 112(1):164-76. PubMed ID: 18591322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Maternal blood intrauterine transfusions in the therapy of red-cell alloimmunization performed in three difficult cases].
    Kucińska-Chahwan A; Massalska D; Bijok J; Rudzińska M; Kopeć I; Rzymkiewicz L; Jakiel G; Roszkowski T
    Ginekol Pol; 2014 Sep; 85(9):703-7. PubMed ID: 25322544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
    Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
    Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal treatment of severe fetomaternal blood group incompatibilities].
    Brossard Y; Chavinié J; Poissonnier MH
    Rev Prat; 1984 Dec; 34(59):3309-14. PubMed ID: 6441239
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.